logo
  

Rick Arredondo Named Chief Banking Officer Of Heritage Oaks Bank

Heritage Oaks Bancorp. (HEOP) Tuesday announced the appointment of Rick Arredondo as President and Chief Banking Officer of Heritage Oaks Bank. Arredondo joined Heritage Oaks Bank on January 5.

The Chief Banking Officer is a newly created position that reports directly to the company's president and chief executive Simone Lagomarsino who will remain the Bank's CEO.

Arredondo will lead the Bank's customer-facing functions, including consumer and business banking, mortgage and marketing. He has more than 40 years of commercial and retail banking experience.

Heritage Oaks said Arredondo has been involved in all aspects of banking, including customer acquisition, lending functions, deposit operations, treasury/cash management services, and mortgage sales and servicing.

Arredondo will serve as a key member of the Heritage Oaks Bank executive team. Prior to joining Heritage Oaks Bank, he served as President and Chief Operating Officer at Rabobank California in Roseville, California, overseeing a network of more than 120 branches.

Prior to this position, Arredondo served as Executive Vice President and Chief Operating Officer at Mellon 1st Business Bank in Los Angeles. He also held management positions at Santa Monica Bank and Bank of America.

Simone Lagomarsino, President and CEO, said, "We are very pleased to have someone with Rick's extensive banking experience join our company. He has the strong banking background and leadership qualities that are important to us. He is a fantastic addition to our executive management team."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT